Viral mimic induces melanoma cells to digest themselves

August 3, 2009,

Recent research has uncovered an unexpected vulnerability in deadly melanoma cells that, when exploited, can cause the cancer cells to turn against themselves. The study, published by Cell Press in the August issue of the journal Cancer Cell, identifies a new target for development of future therapeutics aimed at selectively eliminating this aggressive skin cancer which is characterized by a notoriously high rate of metastasis and treatment-resistance.

"Although considerable effort has been devoted to the search for molecular mechanisms that contribute to the chemo- and immunoresistance of , the average survival of patients with inoperable remains less than 10 months," explains senior study author Dr. Maria S. Soengas from the Melanoma Laboratory at the Spanish National Cancer Research Centre in Madrid, Spain. Melanoma has multiple complex genetic aberrations that make the cells difficult to destroy with current treatments.

One process that has not been studied in great detail with regards to melanoma is a type of autophagy (literally, self-eating) that involves sequestration of components within the cell for eventual degradation. Previous work has linked autophagy with both cancer cell death and survival and it is not clear whether this process might be a viable target for future drug development. Dr. Soengas and colleagues designed a series of studies to examine the interplay between autophagy and cell death in the context of tumor cell-selective elimination of melanoma cells.

The researchers discovered that melanoma cells retain the ability to recognize and respond to double-stranded RNA (dsRNA) located inside the cell cytoplasm. Most animal cells contain single-stranded RNA and see dsRNA, which is associated with viruses, as a threat. The melanoma cells responded to administration of the dsRNA mimic polyinosine-polycytidylic acid (pIC) by inducing an immune response that led to autophagy. However, the method of delivering the pIC to the melanoma cells was critical and required a carrier called polyethyleneimine (PEI) to ensure delivery of pIC to the .

The researchers went on to show that pIC links autophagy to apoptosis, a well studied cell death pathway. Significantly, the cell autonomous anti-tumor activity of pIC was observed even in animals with a suppressed immune system, a condition common to melanoma patients. "Altogether, our results provide the proof of principle for dsRNA sensors as therapeutic targets to overcome the inherent resistance of to current anticancer treatments," says Dr. Soengas.

Importantly, the pIC-PEI complex has two exciting advantages over other anticancer agents. "First, pIC-PEI can induce both autophagy and apoptosis in an efficient manner while other compounds are just partial inducers of one of the two processes. Second, pIC-PEI has a significant anti-melanoma activity in experimental mouse models without noticeable side effects." The researchers caution that further research is required before these results can be translated to the clinic.

Source: Cell Press (news : web)

Related Stories

Recommended for you

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Aug 05, 2009
Meanwhile, remember that the rate of mitosis is sensitive to TEMPERATURE! Cooling any cell or tumor will slow or stop this action! Drugs have a history of remaining when the tumor is gone!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.